Trial Profile
A Safety, Tolerability and Pharmacokinetic Study of LEO 29102 in Subjects With Atopic Dermatitis
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 27 Nov 2014
Price :
$35
*
At a glance
- Drugs LEO 29102 (Primary)
- Indications Atopic dermatitis
- Focus Adverse reactions
- Sponsors LEO Pharma
- 27 Nov 2014 New trial record